Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
CALC
CALC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CALC News
Wall Street Analysts Adjust Ratings
Jan 29 2026
Benzinga
CalciMedica Discontinues Trial, Stock Faces Volatility
Jan 28 2026
stocktwits
CalciMedica Halts KOURAGE Clinical Trial Amid Safety Concerns
Jan 28 2026
Benzinga
U.S. Stocks Mixed as Energy Shares Rise Amid Crude Inventory Decline
Jan 28 2026
Benzinga
U.S. Stocks Mostly Higher; Starbucks Beats Q1 Sales Expectations
Jan 28 2026
Benzinga
CalciMedica Halts Auxora Clinical Trial Due to Safety Concerns
Jan 28 2026
PRnewswire
CalciMedica (CALC) Anticipates Key Phase 2 Data Readout in 2026 with $14.1M Cash Position
Jan 21 2026
NASDAQ.COM
CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
Nov 12 2025
PRnewswire
CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension
Nov 12 2025
PRnewswire
CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025
Nov 10 2025
PRnewswire
CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Sep 02 2025
PRnewswire
CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
Aug 12 2025
PRnewswire
CalciMedica to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference
Jul 08 2025
Newsfilter
CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure
Jun 25 2025
Newsfilter
CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting
Jun 12 2025
Newsfilter
CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
May 14 2025
PRnewswire
Show More News
